Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo (original) (raw)

• Smith, K.A. Interleukin-2: inception, impact, and implications. Science 240, 1169–1176 (1988).
  Article CAS PubMed Google Scholar
• Gillis, S., Gillis, A.E. & Smith, K.A. The detection of a spleen focus-forming virus neoantigen by lymphocyte-mediated cytolysis. J. Exp. Med. 148, 18–31 (1978).
  Article CAS PubMed PubMed Central Google Scholar
• Van Parijs, L. et al. Uncoupling IL-2 signals that regulate T-cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11, 281–288 (1999).
  Article CAS PubMed Google Scholar
• Gillis, S. & Smith, K.A. Long term culture of tumour-specific cytotoxic T cells. Nature 268, 154–156 (1977).
  Article CAS PubMed Google Scholar
• Akbar, A.N. et al. Interleukin-2 receptor common γ-chain signaling cytokines regulate activated T-cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol. 26, 294–299 (1996).
  Article CAS PubMed Google Scholar
• Lenardo, M.J. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353, 858–861 (1991).
  Article CAS PubMed Google Scholar
• Cousens, L.P., Orange, J.S. & Biron, C.A. Endogenous IL-2 contributes to T-cell expansion and IFN-γ production during lymphocytic choriomeningitis virus infection. J. Immunol. 155, 5690–5699 (1995).
  CAS PubMed Google Scholar
• Barouch, D.H. et al. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc. Natl. Acad. Sci. USA 97, 4192–4197 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kuroda, K. et al. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen. J. Immunol. 157, 1422–1431 (1996).
  CAS PubMed Google Scholar
• Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253–261 (1993).
  Article CAS PubMed Google Scholar
• Suzuki, H. et al. Deregulated T-cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268, 1472–1476 (1995).
  Article CAS PubMed Google Scholar
• Willerford, D.M. et al. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521–530 (1995).
  Article CAS PubMed Google Scholar
• Dai, Z., Konieczny, B.T. & Lakkis, F.G. The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells. J. Immunol. 165, 3031–3036 (2000).
  Article CAS PubMed Google Scholar
• Ku, C.C., Murakami, M., Sakamoto, A., Kappler, J. & Marrack, P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288, 675–678 (2000).
  Article CAS PubMed Google Scholar
• Rosenberg, S.A. et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 313, 1485–1492 (1985).
  Article CAS PubMed Google Scholar
• Kovacs, J.A. et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 335, 1350–1356 (1996).
  Article CAS PubMed Google Scholar
• Kovacs, J.A. et al. Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy. Eur. J. Immunol. 31, 1351–1360 (2001).
  Article CAS PubMed Google Scholar
• Davey, R.T. et al. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: a randomized controlled trial. JAMA 284, 183–189 (2000).
  Article CAS PubMed Google Scholar
• Jacobson, E.L., Pilaro, F. & Smith, K.A. Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. Proc. Natl. Acad. Sci. USA 93, 10405–10410 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177–187 (1998).
  Article CAS PubMed Google Scholar
• Matloubian, M., Kolhekar, S.R., Somasundaram, T. & Ahmed, R. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67, 7340–7349 (1993).
  CAS PubMed PubMed Central Google Scholar
• Zajac, A.J. et al. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205–2213 (1998).
  CAS PubMed PubMed Central Google Scholar
• Kaech, S.M. & Ahmed, R. Memory CD8+ T-cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2, 415–422 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wong, P. & Pamer, E.G. Antigen independent CD8 T-cell proliferation. J. Immunol. 166, 5864–5868 (2001).
  Article CAS PubMed Google Scholar
• van Stipdonk, M.J., Lemmens, E.E. & Schoenberger, S.P. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2, 381–382 (2001).
  Article Google Scholar
• von Herrath, M.G., Yokoyama, M., Dockter, J., Oldstone, M.B. & Whitton, J.L. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol. 70, 1072–1079 (1996).
  CAS PubMed PubMed Central Google Scholar
• Lau, L.L., Jamieson, B.D., Somasundaram, T. & Ahmed, R. Cytotoxic T-cell memory without antigen. Nature 369, 648–652 (1994).
  Article CAS PubMed Google Scholar
• Grayson, J.M., Murali-Krishna, K., Altman, J.D. & Ahmed, R. Gene expression in antigen-specific CD8+ T cells during viral infection. J. Immunol. 166, 795–799 (2001).
  Article CAS PubMed Google Scholar
• Murali-Krishna, K. & Ahmed, R. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165, 1733–1737 (2000).
  Article CAS PubMed Google Scholar
• Lotze, M.T. et al. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. J. Immunol. 135, 2865–2875 (1985).
  CAS PubMed Google Scholar
• Lotze, M.T. et al. Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer 58, 2764–2772 (1986).
  Article CAS PubMed Google Scholar
• Mier, J.W. et al. Induction of circulating tumor necrosis factor (TNF α) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J. Clin. Immunol. 8, 426–436 (1988).
  Article CAS PubMed Google Scholar
• Callan, M.F. et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187, 1395–1402 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Wilson, J.D. et al. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS 14, 225–233 (2000).
  Article CAS PubMed Google Scholar
• Jin, X. et al. High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections. J. Infect. Dis. 181, 165–175 (2000).
  Article CAS PubMed Google Scholar
• Komanduri, K.V. et al. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1- infected subjects. Virology 279, 459–470 (2001).
  Article CAS PubMed Google Scholar
• Zhang, X., Sun, S., Hwang, I., Tough, D.F. & Sprent, J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8, 591–599 (1998).
  Article CAS PubMed Google Scholar
• Smith, K. Interleukin 2 immunotherapy. in Therapeutic Immunology (eds. Austen, F., Burakoff, S., Rosen, F. & Strom, T.) 240–250 (Blackwell Science, Oxford, UK, 2001).
  Google Scholar
• Smith, K.A. et al. In vivo assessment of antiviral reactivity in chronic HIV infection. HIV Clin. Trials 1, 16–22 (2000).
  Article CAS PubMed Google Scholar
• Smith, K.A. To cure chronic HIV infection, a new therapeutic strategy is needed. Curr. Opin. Immunol. 13, 617–624 (2001).
  Article CAS PubMed Google Scholar
• Yee, C., Riddell, S.R. & Greenberg, P.D. Prospects for adoptive T-cell therapy. Curr. Opin. Immunol. 9, 702–708 (1997).
  Article CAS PubMed Google Scholar
• Whitmire, J.K. et al. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T-cell responses but is dispensable for CD8 T-cell responses. J. Immunol. 163, 3194–3201 (1999).
  CAS PubMed Google Scholar